Healthcare provider profile · identity verified

Albert Sean Dalley, MD

Internal Medicine · CLEBURNE, TX · NPI 1164478194

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	181
Amlodipine Besylate	Amlodipine Besylate	387	122
Levothyroxine Sodium	Levothyroxine Sodium	374	116
Lisinopril	Lisinopril	328	116
Pantoprazole Sodium	Pantoprazole Sodium	288	104
Gabapentin	Gabapentin	229	79
Rosuvastatin Calcium	Rosuvastatin Calcium	215	76
Tramadol Hcl	Tramadol Hcl	202	54
Metformin Hcl	Metformin Hcl	198	69
Alprazolam	Alprazolam	182	28
Losartan Potassium	Losartan Potassium	181	62
Trazodone Hcl	Trazodone Hcl	164	50
Furosemide	Furosemide	154	53
Sertraline Hcl	Sertraline Hcl	154	45
Metoprolol Succinate	Metoprolol Succinate	142	50
Eliquis	Apixaban	135	29
Montelukast Sodium	Montelukast Sodium	120	42
Acetaminophen-Codeine	Acetaminophen With Codeine	119	28
Tamsulosin Hcl	Tamsulosin Hcl	118	38
Potassium Chloride	Potassium Chloride	114	41
Simvastatin	Simvastatin	114	40
Carvedilol	Carvedilol	111	35
Albuterol Sulfate Hfa	Albuterol Sulfate	109	41
Metoprolol Tartrate	Metoprolol Tartrate	108	35
Clopidogrel	Clopidogrel Bisulfate	106	28
Cefuroxime	Cefuroxime Axetil	105	81
Omeprazole	Omeprazole	102	37
Duloxetine Hcl	Duloxetine Hcl	99	30
Allopurinol	Allopurinol	91	24
Fluticasone Propionate	Fluticasone Propionate	88	45
Hydrochlorothiazide	Hydrochlorothiazide	88	31
Pravastatin Sodium	Pravastatin Sodium	86	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	34
Glimepiride	Glimepiride	80	28
Pregabalin	Pregabalin	77	21
Buspirone Hcl	Buspirone Hcl	75	25
Celecoxib	Celecoxib	75	20
Prednisone	Prednisone	75	39
Mirtazapine	Mirtazapine	66	21
Jardiance	Empagliflozin	62	16
Ozempic	Semaglutide	59	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	21
Meloxicam	Meloxicam	58	23
Tizanidine Hcl	Tizanidine Hcl	58	17
Ondansetron Hcl	Ondansetron Hcl	57	24
Lovastatin	Lovastatin	55	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	36
Linzess	Linaclotide	53	17
Cephalexin	Cephalexin	52	45
Donepezil Hcl	Donepezil Hcl	51	17
Metformin Hcl Er	Metformin Hcl	50	16
Citalopram Hbr	Citalopram Hydrobromide	49	17
Famotidine	Famotidine	49	15
Januvia	Sitagliptin Phosphate	49	13
Vitamin D2	Ergocalciferol (Vitamin D2)	49	17
Lorazepam	Lorazepam	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	15
Clonazepam	Clonazepam	46	suppressed
Ezetimibe	Ezetimibe	46	16
Amoxicillin	Amoxicillin	44	36
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	12
Atenolol	Atenolol	42	11
Methocarbamol	Methocarbamol	42	18
Warfarin Sodium	Warfarin Sodium	42	11
Temazepam	Temazepam	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	14
Memantine Hcl	Memantine Hcl	38	11
Azithromycin	Azithromycin	37	34
Cefdinir	Cefdinir	37	30
Esomeprazole Magnesium	Esomeprazole Magnesium	37	11
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Solifenacin Succinate	Solifenacin Succinate	37	suppressed
Finasteride	Finasteride	35	12
Clonidine Hcl	Clonidine Hcl	34	suppressed
Glipizide	Glipizide	34	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Aripiprazole	Aripiprazole	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Oxybutynin Chloride	Oxybutynin Chloride	30	12
Irbesartan	Irbesartan	29	12
Diazepam	Diazepam	28	suppressed
Levofloxacin	Levofloxacin	27	21
Propranolol Hcl	Propranolol Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	11
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Ramelteon	Ramelteon	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Nitroglycerin	Nitroglycerin	21	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	19
Colesevelam Hcl	Colesevelam Hcl	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Mounjaro	Tirzepatide	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Tradjenta	Linagliptin	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Sucralfate	Sucralfate	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Topiramate	Topiramate	17	suppressed
Torsemide	Torsemide	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Digoxin	Digoxin	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nystatin	Nystatin	15	14
Ramipril	Ramipril	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Estradiol (Once Weekly)	Estradiol	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Constulose	Lactulose	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Valsartan	Valsartan	13	suppressed
Belsomra	Suvorexant	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error